Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -285,305 | -130,778 | N/A | N/A |
| Depreciation Amortization | 5,921 | 1,826 | N/A | N/A |
| Income taxes - deferred | N/A | -7,547 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,982 | -421 | N/A | N/A |
| Other Working Capital | 6,156 | 10,512 | N/A | N/A |
| Other Operating Activity | 133,264 | 40,890 | 0 | 0 |
| Operating Cash Flow | $-137,982 | $-85,518 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -23,872 | -26,124 | N/A | N/A |
| Net Acquisitions | N/A | -3,195 | N/A | N/A |
| Purchase Of Investment | -387,432 | -141,519 | N/A | N/A |
| Sale Of Investment | 158,741 | 82,977 | N/A | N/A |
| Investing Cash Flow | $-252,563 | $-87,861 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 149 | 1 | N/A | N/A |
| Other Financing Activity | 435,538 | 223,739 | 0 | 0 |
| Financing Cash Flow | $435,687 | $223,740 | $N/A | $N/A |
| Beginning Cash Position | 81,807 | 31,446 | N/A | N/A |
| End Cash Position | 126,949 | 81,807 | N/A | N/A |
| Net Cash Flow | $45,142 | $50,361 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -137,982 | -85,518 | N/A | N/A |
| Capital Expenditure | -23,872 | -26,124 | N/A | N/A |
| Free Cash Flow | -161,854 | -111,642 | 0 | 0 |